Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro prices in the UK rose sharply from 1 September 2025, after Eli Lilly increased its list price across the range. The highest-dose pen moved from roughly £122 to around £330 per four-week supply, and private clinic prices have followed suit. If you have noticed the cost climbing, you are not imagining it. Mounjaro is a prescription-only medicine, which means it cannot legally be sold, advertised or obtained without a clinical assessment by a qualified prescriber — and that clinical layer is part of what you are paying for, wherever you go.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Eli Lilly restructured Mounjaro's UK list price on 1 September 2025. Before that date, the highest-dose pen carried a list price of around £122. After it, that same pen was priced at roughly £330. As widely reported at the time, the earlier price had been set as a managed-entry point while Mounjaro was new to the UK market; the September revision brought it closer to prices seen in comparable European countries.
For anyone already on treatment, this was significant. A question our prescribers hear most weeks is whether the price is going to keep rising, or whether this was a one-off correction. Honestly, no one can say with certainty, and if you want to understand the outlook, our page on whether Mounjaro prices are set to rise further looks at what we know. What is clear is that Mounjaro prices going up was a deliberate commercial decision by the manufacturer, not a supply-chain anomaly. Private providers passed the increase through to their treatment prices, which is why the figure you see quoted today will look very different from one you might have noted a year ago.
The increase affected the whole range, though not proportionally. If you want to understand how the shift played out across individual doses, including a closer look at what 5mg Mounjaro costs following the restructure, the full Mounjaro UK pricing picture covers that in more detail. The short version: the lower starter doses rose less steeply in absolute terms, but no dose was left unchanged.
Private Mounjaro prices are typically quoted per pen or per month. Reported private market figures since September 2025 range from roughly £149 to £375 a month, depending on dose and provider. That spread is wide, and it reflects real differences in what is and is not included.
A headline price from some providers covers the pen alone. Consultation fees, prescription charges and delivery costs appear separately, sometimes at checkout, sometimes only if you look for them. Dose-review support, aftercare access and repeat-prescription reviews may be billed as add-ons or simply absent. When you are comparing figures, it is worth asking what the total cost of a month's treatment actually is, not just the cost of the medicine itself.
The breakdown of what drives Mounjaro pen pricing in the UK goes into this further if you want the granular version. For now, the practical point is this: two providers quoting similar figures may be offering very different levels of clinical oversight. For a prescription-only medicine with a titration schedule managed by a prescriber, that distinction matters.
At nume, sorry, at nume, one transparent price covers the consultation, the prescription, the treatment itself and free next-working-day tracked delivery. There are no subscription charges, no automatic renewals and no separate clinical fees. Before every repeat order, a GPhC-registered prescriber reviews your case again, not a questionnaire scoring algorithm, but a named clinician reading your information. That review is included.
We are not the cheapest option in the market. That is a deliberate choice. The clinical infrastructure that makes treatment safe (identity verification, live weight checks, GP notification, evidence review at each dose step) adds cost, and we do not strip it out to win a price comparison. What a lower headline number sometimes represents is a thinner process. For a medicine like Mounjaro, a thinner process is not a saving; it is a risk.
If you want to see what treatment through nume's weight-loss service (nume's weight-loss service) involves in practice, the treatment page sets it out. The price shown there is the price you pay.
The MHRA has warned publicly and repeatedly about counterfeit weight-loss pens sold through social media and unofficial websites. In a 2025 enforcement operation, investigators seized roughly 20 million doses of illegally traded weight-loss medicines with an estimated street value of around £45 million. A first illicit manufacturing site producing fake tirzepatide pens was raided in Northampton in October 2025. Counterfeit pens have contained insulin in place of tirzepatide, with serious consequences for patients who used them.
The sellers behind those products often advertise prices well below anything a legitimate licensed pharmacy can offer. If a price looks startlingly low, that gap is worth interrogating before you hand over payment details. Any registered UK online pharmacy can be checked in seconds on the GPhC pharmacy register. A seller offering Mounjaro without a prescription-based clinical assessment, regardless of how credible their site looks, is operating outside the law.
For more context on how to evaluate what you are being offered, the Mounjaro pricing guide covers the legitimacy signals that matter. The right question when Mounjaro prices are rising is not where to find the lowest number, it is where to find genuine medicine, dispensed legally, reviewed by a real prescriber. That question has a much shorter list of answers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.